• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Unspecified Infection (1930); Ulcer (2274); Patient Problem/Medical Problem (2688)
Event Date 08/02/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician used venaseal closure system to treat 1 segment of the great saphenous vein (gsv).The ifu was followed during preparation, procedure and post-procedure.The guide wire was used for insertion of the catheter.It was reported the access site closed post procedure, but patient had a hematoma and infection at the access site and had an ulcer develop at this access site.No further patient injury reported for this event.
 
Manufacturer Narrative
Additional information: physician used venaseal closure system to treat chronic venous insufficiency in right great saphenous vein.1.5mls of adhesive was u sed, the lumen was flushed prior to use.Compression was used.The patient was treated with antibiotics.No further treatment reported.The patient is reported to being well and will be reviewed at the tissue viability unit.The patient was reviewed during a follow-up appointment, it was reported there is significant improvement.The ulcer is doing well.On examination an approximately 1cm ulcer on the medial aspect of the right leg just below the knee was noted.This is clean and there is granulation tissue in the base of the ulcer.There are no signs of infection at present and the wound is dry, but patient appears to be reacting to the sticky part of the mepore dressing so this has not be re-applied.Patient will be reviewed again in two weeks and four weeks and has been advised to regularly change the dressing.Patient is receiving wound care management.Patient discharged following wound care management.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Image review: one image received from customer show ulceration of the access cite.The area of infection showed red/purple color throughout the wound.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8892048
MDR Text Key154233696
Report Number9612164-2019-03380
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeMT
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSP-101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/23/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-